non-small-cell-lung-cancer

Documents about non-small-cell-lung-cancer

• Study of AVE0005 (VEGF Trap) in Locally Advanced or Metastatic Platinum- and Erlotinib- Resistant Non-small-cell-lung Adenocarcinoma#838994ClinicalTrials.gov
• Study for Patients With Non Small Cell Lung Cancer (NSCLC)#805731ClinicalTrials.gov
• SHR-1701 Combined With Fluzoparib in Lung Squamous Cell Carcinoma#226238ClinicalTrials.gov
• Identification of Marker of Primary or Acquired Resistance to Anti Tumorous Treatment#824899ClinicalTrials.gov
• Epidemiological Study to Describe Non Small Cell Lung Cancer Clinical Management Patterns in MENA. Lung-EPICLIN/ Gulf#806363ClinicalTrials.gov
• Oncology Research Information Exchange Network (ORIEN) Lung Cancer Study#394774ClinicalTrials.gov
• Study of Tislelizumab for Locally Advanced Non-Small Cell Lung Cancer Following Neoadjuvant Chemotherapy Plus Tislelizumab ± Bevacizumab and Definitive Concurrent Chemoradiation Therapy#442079ClinicalTrials.gov
• AI-guided Prognostication and Cranial Radiotherapy Optimization in EGFR-TKI-treated Non-small Cell Lung Cancer Patients With Baseline Brain Metastases#807451ClinicalTrials.gov
• Electroacupuncture Combined With Immune Checkpoint Inhibitors as Adjuvant Therapy After Surgery for Early-stage Non-small Cell Lung Cancer#840354ClinicalTrials.gov
• ImmuniCell® in Patients With Advanced Cancers#394754ClinicalTrials.gov
• A Trial to Learn How the Cancer Vaccine BNT116 in Combination With Cemiplimab Works and How Safe the Combination is in Adults With Advanced Non-small Cell Lung Cancer (EMPOWERVAX Lung 1)#314319ClinicalTrials.gov
• Quick Start Durvalumab Following Chemoradiation for Stage III Nonsmall Cell Lung Cancer#377334ClinicalTrials.gov
• Metformin in Stage IV Lung Adenocarcinoma#383532ClinicalTrials.gov
• Evaluation of JSKN016 in the Treatment of Advanced Non-small Cell Lung Cance： a Phase II Clinical Study#261501ClinicalTrials.gov
• Iressa vs Placebo as Maintenance Therapy in Locally Advanced NSCLC#805008ClinicalTrials.gov
• Identification of a Predictive Metabolic Signature of Response to Immune Checkpoint Inhibitors in Non-Small Cell Lung Carcinoma#811889ClinicalTrials.gov
• Study to Evaluate Using Nelfinavir With Chemoradiation for Non-small Cell Lung Cancer#826232ClinicalTrials.gov
• Neoadjuvant Sacituzumab Govitecan Plus Pembrolizumab in Resectable Non-Small Cell Lung Cancer#123479ClinicalTrials.gov
• IDO Peptid Vaccination for Stage III-IV Non Small-cell Lung Cancer Patients.#387150ClinicalTrials.gov
• Trial of RAD001 in Patients With Operable Non-Small Cell Lung Cancer (NSCLC)#807209ClinicalTrials.gov
• Immunotherapy Without Chemotherapy for Advanced Lung Cancer Patients With High PD-L1 Levels#272345ClinicalTrials.gov
• A Global Study of Volrustomig (MEDI5752) Plus Chemotherapy Versus Pembrolizumab Plus Chemotherapy for Participants With Metastatic Non-small Cell Lung Cancer.#834966ClinicalTrials.gov
• Testing the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy Treatment During Radiation Therapy for Superior Sulcus Non-small Cell Lung Cancer#460080ClinicalTrials.gov
• Testing the Use of Combination Immunotherapy Treatment (N-803 [ALT-803] Plus Pembrolizumab) Against the Usual Treatment for Advanced Non-small Cell Lung Cancer (A Lung-MAP Treatment Trial)#837761ClinicalTrials.gov
• I3LUNG: Integrative Science, Intelligent Data Platform for Individualized LUNG Cancer Care With Immunotherapy#136313ClinicalTrials.gov
• Plasma Protein Analysis for Biomarker Discovery in Lung Cancer Treated With Atezolizumab Combination Therapy in J-TAIL-2#338826OKAYAMA UNIVERSITY SCIENTIFIC ACHIEVEMENT REPOSITORY
• Safety and Efficiency of γδ T Cell Against Non Small Lung Cancer ( Without EGFR Mutation)#146464ClinicalTrials.gov
• Tepotinib vs Standard Treatment in Patients With Advanced MET Exon 14 Mutated Non-Small Cell Lung Cancer Previously Treated#303739ClinicalTrials.gov
• Safety and Efficacy of DC-CIK in Patients With Advanced Non-Small-Cell Lung Cancer With Bone Metastases#346941ClinicalTrials.gov
• Evaluation of the Idylla ctEGFR mutation assay to detect EGFR mutations in plasma from patients with non-small cell lung cancers#388220HAL (France)
• QUILT-2.024: Phase 2 Neoadjuvant, Consolidation, and Adjuvant Combination NANT Immunotherapy Versus Standard of Care in Subjects With Resectable Non-small Cell Lung Cancer#833520ClinicalTrials.gov
• Clinical Application Study of PET/CT for Differential Diagnosis of Non-small Cell Lung Cancer#366603ClinicalTrials.gov
• Uncovering the mechanisms of synergistic drug combinations in non-small cell lung cancer through metagene-based classification#174821PLOS
• Bright Light Therapy in Patients With Melanoma or Non-small Cell Lung Cancer (NSCLC) Who Are Receiving First-Line Immune Checkpoint Blockade#346913ClinicalTrials.gov
• ITIL-306 in Advanced Solid Tumors#226274ClinicalTrials.gov
• A Multicenter Clinical Trial of Sputum DNA Testing for Lung Cancer in China#826419ClinicalTrials.gov
• A Study of 5 Years of Adjuvant Osimertinib in Completely Resected Epidermal Growth Factor Receptor Mutation (EGFRm) Non-small Cell Lung Carcinoma (NSCLC)#804700ClinicalTrials.gov
• Radical RADiotherapy and Immunotherapy for Metastatic CAncer of the Lung (RRADICAL)#238124ClinicalTrials.gov
• Vaccine Therapy in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer#287372ClinicalTrials.gov
• Predictive Value of Exosomes in Pleural Effusion for Advanced Lung Cancer#432894ClinicalTrials.gov
• Study of Nivolumab-Ipilimumab and cfDNA in Lung Cancer#802607ClinicalTrials.gov
• TR(ACE) Assay Clinical Specimen Study#800548ClinicalTrials.gov
• DeepGR: a deep-learning prognostic model based on glycolytic radiomics for non-small cell lung cancer#28883HAL (France)
• Gender matters. Sex-related differences in immunotherapy outcome in patients with non-small cell lung cancer#330406IRIS
• LUNAR-4: Effect of Tumor Treating Fields (TTFields) (150 kHz) Concurrent With Pembrolizumab for Treatment of Metastatic Non-small Cell Lung Cancer (NSCLC)#810833ClinicalTrials.gov
• A Study to Assess the Efficacy of WSD0922-FU in Patients With C797S+ Advanced Non-small Cell Lung Cancer#813518ClinicalTrials.gov
• Pembrolizumab With or Without Maintenance Sacituzumab Tirumotecan (Sac-TMT; MK-2870) in Metastatic Squamous Non-small Cell Lung Cancer (NSCLC) [MK-2870-023]#829200ClinicalTrials.gov
• Therapeutic and Prognostic Impact of Circulating Tumor Cells in Peripheral Blood in Patients With Non Small-cell Lung Cancer#829443ClinicalTrials.gov
• Pembrolizumab in Preventing Lung Cancer in Patients With Stage I-II Non-Small Cell Lung Cancer or High-Risk Pulmonary Nodules, the IMPRINT-Lung Study#373610ClinicalTrials.gov
• Cardiopulmonary Toxicity of Thoracic Radiotherapy#332854ClinicalTrials.gov